PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$102.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Oxford University Press
23 December 2021
Telemedicine has recently become a key focus of healthcare systems globally, heavily influenced by the COVID-19 pandemic and the increased need for remote care pathways. Implementing telemedicine can bring myriad benefits for both patients and providers, and has the potential to make a huge impact by improving access to abortion care.

In both the United Kingdom and United States, abortion is heavily regulatedDLexceptionally so when compared to other routine healthcare. This regulation has had the impact of exacerbating the social and geographical circumstances that can make access to abortion services difficult.

This book examines telemedical provision of early medical abortion, alongside the access barriers created by laws in the United Kingdom and United States. It critically appraises a series of developments in this rapidly evolving subject, providing an up-to-date and well-informed analysis. In doing so, it argues that there is a moral imperative to introduce, retain, or reinstate (as applicable) telemedical early medical abortion.

By:   , , , ,
Imprint:   Oxford University Press
Country of Publication:   United Kingdom
Dimensions:   Height: 233mm,  Width: 157mm,  Spine: 12mm
Weight:   370g
ISBN:   9780192896155
ISBN 10:   0192896156
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Introduction 1: Understanding Early Medical Abortion 2: Abortion exceptionalism and the law in the United Kingdom and United States 3: Socio-legal barriers to early medical abortion 4: Piecemeal progression and home use of misoprostol in the United Kingdom 5: Early medical abortion and the telemedical imperative 6: A telemedical continuum for early medical abortion 183 7: The necessity of telemedical abortion during a pandemic 8: The legal and policy response to abortion care in the United Kingdom during COVID-19 9: Legal and policy restrictions on telemedical early medical abortion in the United States during COVID-19 Conclusion Appendix - United Kingdom chronology Appendix - United States chronology Appendix - Demand-side TRAP laws in the United States Appendix - Abortion provider restrictions in the United States Appendix - State regulation of exchange health policies in the United States Appendix - Limitations on the use of state funds in the United States Appendix - State barriers to TEMA in the United States

Jordan A. Parsons is a PhD candidate at Bristol Medical School. His PhD is supported by the Wellcome Trust and explores decisions made with, for, and on behalf of cognitively impaired adults with kidney failure - particularly in relation to the choice between dialysis and conservative kidney management. Jordan's work is at the intersection of bioethics, medical law, and health policy. His wider research interests include sexual and reproductive health, organ transplantation law and policy, ethical issues in nephrology, genetic privacy, and theory in public policy. Dr Elizabeth Chloe Romanis is Assistant Professor in Biolaw at Durham Law School. Chloe passed her Wellcome Trust-funded PhD at the University of Manchester on artificial womb technology in 2020 with no corrections and was awarded the University of Manchester distinguished achievement medal for humanities research student of the year. She has published extensively on the ethico-legal issues in gestation surrounding the development of artificial womb technologies, on abortion law and policy, and on choice in childbirth. Her broader research interests include sexual and reproductive health law, feminist legal theory, and comparative law. Chloe currently teaches Contemporary Issues in Biolaw and Contract Law at Durham.

See Also